Ezra M. Friedberg, Director at Chromocell Therapeutics Corp (CHRO), bought 16,667 shares at $6.00 ($100K) on 2024-02-21, disclosed to the SEC on 2024-03-12.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| PTHS | SELL | 2026-04-06 | $12K | — | Filing → |
| PTHS | SELL | 2025-11-26 | $280K | — | Filing → |